Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Scott Best

3PUBLICATIONS
27CO-AUTHORS
ChemotherapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 07, 2026
Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

|Apr 23, 2025
In vivo functional screens reveal <i>KEAP1</i> loss as a driver of chemoresistance in small cell lung cancer.

Lauren Brumage, Scott Best, Daniel S Hippe

|Jul 07, 2023
T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Vi Lam, Carly Roleder, Tingting Liu

Pageof 1

Frequent Collaborators

2 joint publications

David MacPherson

2 joint publications

Lucas Sullivan

2 joint publications

Pritha Chanana

2 joint publications

Daniel S Hippe

1 joint publications

Carly Roleder

1 joint publications

Tingting Liu

1 joint publications

Amanda G Paulovich

1 joint publications

Xiaoguang Wang

1 joint publications

Tycel Phillips

1 joint publications

Allison J Berger

Frequent Collaborators

2 joint publications

David MacPherson

2 joint publications

Lucas Sullivan

2 joint publications

Pritha Chanana

2 joint publications

Daniel S Hippe